Trials / Completed
CompletedNCT02032979
Neurological and Psychiatric Comorbidities Patients With FSHD 1 and 2
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Centre Hospitalier Universitaire de Nice · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The investigators propose to conduct a comparative pilot cognitive and psychiatric profiles of 10 patients Facio-Scapulo-Humeral Dystrophy (= FHSD) type 1 and 10 patients with type 2 FSHD study. For this, the investigators relied on observational components: FSHD2 patients appear more often present with psychiatric comorbidities and seem to have lower cognitive performance compared to FSHD1 patients. This was confirmed by a preliminary study on a small sample population of patients. It seems to exist mainly executive dysfunction associated with attention disorders in patients FSHD2. Moreover, their performance in IQ tests would be low in relation to their socio-educational and compared with patients FSHD1 level.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Psychiatric test |
Timeline
- Start date
- 2014-10-20
- Primary completion
- 2015-07-01
- Completion
- 2015-07-01
- First posted
- 2014-01-10
- Last updated
- 2023-11-14
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02032979. Inclusion in this directory is not an endorsement.